Errichetti, Enzo, Peter Wolf, Saakshi Khattri, Patricia Gorecki, Megan Miller, Jingzhi Jiang, Chenglong Han, and Brian Kirby. “Patients With Persistent Mild Psoriasis After Treatment With Ustekinumab Achieved Greater Improvements in Skin Clearance and Patient-Reported Outcomes After Switching to Guselkumab in the Phase 3 NAVIGATE Trial”. Acta Dermato-Venereologica 104 (September 5, 2024): adv41053. Accessed November 21, 2024. https://medicaljournalssweden.se/actadv/article/view/41053.